A Multicenter, Propensity Score–Matched Assessment of Endoscopic Versus Microscopic Approaches in the Management of Pituitary Adenomas

BACKGROUND There is considerable controversy as to which of the 2 operating modalities (microsurgical or endoscopic transnasal surgery) currently used to resect pituitary adenomas (PAs) is the safest and most effective intervention. OBJECTIVE To compare rates of clinical outcomes of patients with PAs who underwent resection by either microsurgical or endoscopic transnasal surgery. METHODS To independently assess the outcomes of each modality type, we sought to isolate endoscopic and microscopic PA surgeries with a 1:1 tight-caliper (0.01) propensity score-matched analysis using a multicenter, neurosurgery-specific database. Surgeries were performed between 2017 and 2020, with data collected retrospectively from 12 international institutions on 4 continents. Matching was based on age, previous neurological deficit, American Society of Anesthesiologists (ASA) score, tumor functionality, tumor size, and Knosp score. Univariate and multivariate analyses were performed. RESULTS Among a pool of 2826 patients, propensity score matching resulted in 600 patients from 9 surgery centers being analyzed. Multivariate analysis showed that microscopic surgery had a 1.91 odds ratio (OR) (P = .03) of gross total resection (GTR) and shorter operative duration (P < .01). However, microscopic surgery also had a 7.82 OR (P < .01) for intensive care unit stay, 2.08 OR (P < .01) for intraoperative cerebrospinal fluid (CSF) leak, 2.47 OR (P = .02) for postoperative syndrome of inappropriate antidiuretic hormone secretion (SIADH), and was an independent predictor for longer postoperative stay (β = 2.01, P < .01). Overall, no differences in postoperative complications or 3- to 6-month outcomes were seen by surgical approach. CONCLUSION Our international, multicenter matched analysis suggests microscopic approaches for pituitary tumor resection may offer better GTR rates, albeit with increased intensive care unit stay, CSF leak, SIADH, and hospital utilization. Better prospective studies can further validate these findings as matching patients for outcome analysis remains challenging. These results may provide insight into surgical benchmarks at different centers, offer room for further registry studies, and identify best practices.

[1]  R. Rennert,et al.  Microscopic Transsphenoidal Surgery in the Era of Endoscopy: Are There Any Advantages? , 2022, Otolaryngologic clinics of North America.

[2]  Pin-Yuan Chen,et al.  Endoscopic transsphenoidal surgery for resection of pituitary macroadenoma: A retrospective study , 2021, PloS one.

[3]  J. V. Van Gompel,et al.  Pituitary Tumor Surgery: Comparison of Endoscopic and Microscopic Techniques at a Single Center. , 2021, Mayo Clinic proceedings.

[4]  Xin Li,et al.  A Meta-Analysis of Endoscopic vs. Microscopic Transsphenoidal Surgery for Non-functioning and Functioning Pituitary Adenomas: Comparisons of Efficacy and Safety , 2021, Frontiers in Neurology.

[5]  Wei Huang,et al.  Comparison of outcomes between endoscopic and microscopic transsphenoidal surgery for the treatment of pituitary adenoma: a meta-analysis. , 2020, Gland surgery.

[6]  F. Poulsen,et al.  Endoscopic vs. microscopic transsphenoidal pituitary surgery: a single centre study , 2020, Scientific Reports.

[7]  A. Mamelak,et al.  Trends in endoscopic and microscopic transsphenoidal surgery: a survey of the international society of pituitary surgeons between 2010 and 2020 , 2020, Pituitary.

[8]  M. Abouzari,et al.  Endoscopic versus nonendoscopic surgery for resection of pituitary adenomas: a national database study. , 2020, Journal of neurosurgery.

[9]  B. Martin,et al.  Transsphenoidal Resection of Pituitary Tumors in the United States, 2009 to 2011: Effects of Hospital Volume on Postoperative Complications , 2020, Journal of Neurological Surgery Part B: Skull Base.

[10]  J. Fernandez-Miranda,et al.  Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the Transsphenoidal Extent of Resection (TRANSSPHER) Study. , 2020, Journal of neurosurgery.

[11]  N. Salamon,et al.  Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors , 2019, Journal of the Endocrine Society.

[12]  O. Dekkers,et al.  Microscopic versus endoscopic transsphenoidal surgery in the Leiden cohort treated for Cushing’s disease: surgical outcome, mortality, and complications , 2019, Orphanet Journal of Rare Diseases.

[13]  M. Weiss,et al.  Complications associated with microscopic and endoscopic transsphenoidal pituitary surgery: experience of 1153 consecutive cases treated at a single tertiary care pituitary center. , 2019, Journal of neurosurgery.

[14]  S. Jain,et al.  Endoscopic versus Microscopic Pituitary Adenoma Surgery: An Institutional Experience , 2018, Asian journal of neurosurgery.

[15]  R. Mekary,et al.  Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis , 2018, Acta Neurochirurgica.

[16]  P. Chanson,et al.  Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement , 2017, Pituitary.

[17]  T. Schwartz,et al.  Endoscopic Endonasal Versus Microscopic Transsphenoidal Surgery for Recurrent and/or Residual Pituitary Adenomas. , 2017, World neurosurgery.

[18]  Lai Wei,et al.  Short-term outcome of endoscopic versus microscopic pituitary adenoma surgery: a systematic review and meta-analysis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[19]  K. Markou,et al.  Endoscopic versus microscopic trans‐sphenoidal pituitary surgery: a systematic review and meta‐analysis , 2011, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[20]  M. Bassim,et al.  Minimally Invasive Pituitary Surgery , 2008, The Laryngoscope.

[21]  W. Couldwell Transsphenoidal and Transcranial Surgery for Pituitary Adenomas , 2004, Journal of Neuro-Oncology.

[22]  E. Oldfield,et al.  Resection of suprasellar tumors by using a modified transsphenoidal approach. Report of four cases. , 2000, Journal of Neurosurgery.

[23]  R. Welbourn The evolution of transsphenoidal pituitary microsurgery. , 1986, Surgery.